BR9914644A - Composições tamponadas para diálise - Google Patents

Composições tamponadas para diálise

Info

Publication number
BR9914644A
BR9914644A BR9914644-4A BR9914644A BR9914644A BR 9914644 A BR9914644 A BR 9914644A BR 9914644 A BR9914644 A BR 9914644A BR 9914644 A BR9914644 A BR 9914644A
Authority
BR
Brazil
Prior art keywords
dialysis
compositions
dialysate
buffered compositions
buffering agent
Prior art date
Application number
BR9914644-4A
Other languages
English (en)
Inventor
Robin Callan
Walter A Van Schalkwijk
Original Assignee
Advanced Renal Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26802194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9914644(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advanced Renal Technologies filed Critical Advanced Renal Technologies
Publication of BR9914644A publication Critical patent/BR9914644A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"COMPOSIçõES TAMPONADAS PARA DIáLISE" Descreve-se concentrados ácidos, e composições de dialisados preparadas a partir deles, contendo ácido cítrico e uma quantidade eficaz de um agente tamponador selecionado entre acetato e/ou lactato. O agente tamponador permite que uma quantidade fisiologicamente aceitável de citrato mantenha o pH desejado do dialisado.
BR9914644-4A 1998-10-20 1999-10-19 Composições tamponadas para diálise BR9914644A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10504998P 1998-10-20 1998-10-20
US17606398A 1998-10-20 1998-10-20
PCT/US1999/024583 WO2000023086A2 (en) 1998-10-20 1999-10-19 Buffered compositions for dialysis

Publications (1)

Publication Number Publication Date
BR9914644A true BR9914644A (pt) 2001-10-09

Family

ID=26802194

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914644-4A BR9914644A (pt) 1998-10-20 1999-10-19 Composições tamponadas para diálise

Country Status (22)

Country Link
EP (3) EP1721606B1 (pt)
JP (3) JP4932084B2 (pt)
CN (1) CN1188136C (pt)
AR (2) AR020918A1 (pt)
AT (1) ATE321563T1 (pt)
AU (1) AU765029B2 (pt)
BR (1) BR9914644A (pt)
CA (1) CA2347447C (pt)
CO (1) CO5160318A1 (pt)
CY (1) CY1107496T1 (pt)
DE (2) DE69930676D1 (pt)
DK (2) DK1721606T3 (pt)
EG (1) EG24303A (pt)
ES (2) ES2262363T5 (pt)
HK (1) HK1097466A1 (pt)
IL (2) IL142648A0 (pt)
MX (1) MXPA01003969A (pt)
MY (1) MY125622A (pt)
NZ (1) NZ511172A (pt)
PT (2) PT1721606E (pt)
TW (1) TWI240630B (pt)
WO (1) WO2000023086A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
EP1218039B1 (en) * 1999-09-22 2009-02-18 Advanced Renal Technologies Use of high citrate dialysate
GR1003567B (el) * 2000-06-28 2001-04-10 Νεωτερα ενιαια και σταθερα αμινοξεων-διττανθρακικων πλεονεκτικα διαλυματα για την περιτοναικη καθαρση και αιμοκαθαρση.
JP5204359B2 (ja) * 2001-09-28 2013-06-05 味の素株式会社 透析用剤およびその製造方法
US7053059B2 (en) * 2003-07-25 2006-05-30 Baxter International Inc. Dialysis solutions with reduced levels of glucose degradation products
US8367731B2 (en) 2005-05-30 2013-02-05 Fresenius Medical Care Deutschland Gmbh Peritoneal dialysis fluid
JP5371278B2 (ja) * 2008-04-03 2013-12-18 エイワイファーマ株式会社 透析用剤およびその製造方法
JP5560539B2 (ja) * 2008-06-13 2014-07-30 ニプロ株式会社 透析液調製装置
ES2332636B1 (es) * 2008-08-06 2011-02-10 Universitat De Les Illes Balears Composicion de liquido de dialisis.
CA2764838C (en) 2009-06-17 2018-05-01 Fresenius Medical Care Holdings, Inc. Methods of regional citrate anticoagulation dialysis
RU2438663C1 (ru) 2010-10-18 2012-01-10 Общество с ограниченной ответственностью "Научно-производственное объединение "Нефрон" (ООО "НПО "Нефрон") Способ получения гемодиализирующего раствора для бикарбонатного гемодиализа
CH712274B1 (fr) * 2016-03-18 2020-06-30 Hemo Plus Sarl Unité pour la préparation d'au moins une solution de concentrés pour hémodialyse et procédé de préparation de cette solution.
CN107281098A (zh) * 2017-06-30 2017-10-24 华仁药业股份有限公司 一种血液滤过置换液
CN107890568A (zh) * 2017-10-31 2018-04-10 华仁药业股份有限公司 一种低危害的血液滤过置换液及其制备工艺
CN112167264B (zh) * 2020-10-28 2021-10-26 广州吾同生态科技有限公司 一种次氯酸电解液、次氯酸消毒液及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929871A1 (de) * 1979-07-24 1981-01-29 Gambro Dialysatoren Waessriges konzentrat fuer dialyse-loesungen
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
EP0457960A3 (en) * 1990-05-17 1993-01-07 Minntech Corporation High acid concentration dialysates
EP0567452B1 (en) * 1990-12-18 1996-05-15 The Board Of Regents Of The University Of Washington Dialysate production system with dialysate pellets
DE4114908A1 (de) * 1991-05-07 1992-11-12 Klaus Dr Med Sodemann Dialyseloesung zur dialysebehandlung, konzentrat und vorrichtung zur dialysebehandlung
HUT68062A (en) * 1992-06-03 1995-05-29 Minntech Corp Method and liquids includiug hydrochloric acid for hemodialysis, and concentrate of two container for hemodialysing equipment
JP3398184B2 (ja) * 1993-03-30 2003-04-21 味の素ファルマ株式会社 透析用剤
WO1996001118A1 (en) * 1994-07-01 1996-01-18 Baxter International Inc. Biochemically balanced peritoneal dialysis solutions
JP3530235B2 (ja) * 1994-09-27 2004-05-24 味の素ファルマ株式会社 血液透析用剤
DE19631124A1 (de) * 1996-08-01 1998-02-05 Fresenius Medical Care De Gmbh Verfahren zur Herstellung einer Bicarbonat enthaltenden Infusions- oder Dialysierlösung
JP3619921B2 (ja) * 1996-09-13 2005-02-16 富田製薬株式会社 重炭酸固形透析用剤
DE19654746C2 (de) * 1996-12-30 2000-05-11 Klaus Sodemann Dialyselösung

Also Published As

Publication number Publication date
AR077487A2 (es) 2011-08-31
DK1124567T4 (da) 2011-09-26
ES2262363T3 (es) 2006-11-16
JP2012066088A (ja) 2012-04-05
JP2002527482A (ja) 2002-08-27
CY1107496T1 (el) 2013-03-13
EG24303A (en) 2009-01-12
DE69930676D1 (de) 2006-05-18
CN1188136C (zh) 2005-02-09
MY125622A (en) 2006-08-30
HK1097466A1 (en) 2007-06-29
PT1721606E (pt) 2013-12-16
DK1124567T3 (da) 2006-08-07
AU765029B2 (en) 2003-09-04
PT1124567E (pt) 2006-08-31
DK1721606T3 (da) 2013-12-16
EP1124567B1 (en) 2006-03-29
DE69930676T4 (de) 2007-08-16
IL142648A0 (en) 2002-03-10
WO2000023086A3 (en) 2000-07-27
WO2000023086A2 (en) 2000-04-27
EP1721606B1 (en) 2013-09-11
TWI240630B (en) 2005-10-01
CA2347447C (en) 2009-08-04
EP1721606A2 (en) 2006-11-15
CN1328467A (zh) 2001-12-26
EP2452685A1 (en) 2012-05-16
EP1124567A2 (en) 2001-08-22
NZ511172A (en) 2004-12-24
CA2347447A1 (en) 2000-04-27
EP1721606A3 (en) 2009-06-17
EP1124567B2 (en) 2011-06-29
DE69930676T3 (de) 2012-02-02
ES2438971T3 (es) 2014-01-21
AR020918A1 (es) 2002-06-05
DE69930676T2 (de) 2007-03-29
JP2014043447A (ja) 2014-03-13
JP5975962B2 (ja) 2016-08-23
ES2262363T5 (es) 2011-11-21
IL142648A (en) 2006-08-20
JP4932084B2 (ja) 2012-05-16
AU1448100A (en) 2000-05-08
CO5160318A1 (es) 2002-05-30
ATE321563T1 (de) 2006-04-15
MXPA01003969A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
ATE464057T1 (de) Gepufferte dialyselösung
BR9914644A (pt) Composições tamponadas para diálise
DE69931159D1 (de) Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
BR0013157A (pt) Composições farmacêuticas e nutricionais contendo ácidos graxos essenciais e agentes de abaixamento da homocisteìna
FR2802425B1 (fr) Utilisation d'un extrait d'au moins un vegetal de la famille des ericaceae comme agent anti-glycation
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
DE69937562D1 (de) Verbessertes angereichertes blutplättchen wundheilmittel
AU2845599A (en) Pharmaceutical compositions and their use
HN1999000183A (es) Preparado farmaceuticos de moxifloxacina
DE69631329D1 (de) Menschlicher wachstumsfaktor (hgf), verändert durch polyethylenglykol
NO20022201L (no) Lösninger inneholdende Epinastin
BR0212075A (pt) Combinações de substâncias ativas fungicidas
PT998287E (pt) Utilizacao de levobupivacaina
TR200400234T4 (tr) ''Stabil, nazal, oral veya sublingual uygulanabilen, desmopressin ihtiva eden farmasötik preparasyon''
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
HUP9900507A2 (hu) Levobupivacaine alkalmazása terhesség esetén használható érzéstelenítő hatású gyógyszerkészítmények előállítására
BRPI0410374A (pt) composição farmacêutica que compreende valsartano
WO2002058488A3 (en) Composition containing creatine and phosphorus
BR0210063A (pt) Composição estável e uso da mesma
MD980129A (en) Antiherpetic remedy
AR008764A1 (es) Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo.
SE9003181D0 (sv) Use of heparin fraction

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 9/08, A61K 33/14, A61P 13/12

Ipc: A61K 33/14 (2009.01), A61P 13/12 (2009.01)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O,11 E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25G Requested change of headquarter approved

Owner name: ADVANCED RENAL TECHNOLOGIES INC. (US)

Free format text: ENDERECO ALTERADO CONFORME SOLICITADO NA PETICAO NO 020100021829/RJ DE 12/03/2010.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]